India Diabetes Research Foundation, Dr. A. Ramachandran's Diabetes Hospitals, 110, Anna Salai, Guindy, Chennai, 600 032, India.
Sci Rep. 2021 Oct 13;11(1):20327. doi: 10.1038/s41598-021-99784-x.
To study the association and possible predictive role of visfatin, resistin, fetuin-A and chemerin with incident type 2 diabetes (T2DM) among Asian Indians with prediabetes. Their association with insulin resistance, β-cell function, glycaemia and anthropometry were also studied. This is a nested case-control study of a large 2-year prospective prevention trial in persons at high risk of developing T2DM. Baseline HbA1c values between 6.0% (42 mmol/mol) and 6.2% (44 mmol/mol) were chosen for this analysis (n = 144). At follow-up, persons with incident T2DM (HbA1c ≥ 6.5%, 48 mmol/mol) were grouped as cases (n = 72) and those reverted to normoglycaemia, (HbA1c < 5.7% (39 mmol/mol) as controls (n = 72). Insulin resistance showed the strongest association with incident T2DM ((Odds Ratio (OR): 23.22 [95%CI 6.36-84.77]; p < 0.0001). Baseline visfatin (OR: 6.56 [95%CI 2.21-19.5]; p < 0.001) and fetuin-A (OR: 1.01 [95%CI (1.01-1.04)]; p < 0.0001) independently contributed to the conversion of prediabetes to T2DM. The contribution was significantly higher when their elevated levels coexisted (OR: 12.63 [95%CI 3.57-44.63]; p < 0.0001). The area under the curve was 0.77 ± SE 0.4 (95%CI 0.69-0.85) and 0.80 ± SE 0.04 (95%CI 0.73-0.88) for visfatin (median 17.7 ng/ml, sensitivity and specificity: 75%, p < 0.0001) and fetuin-A (mean 236.2 µg/ml, sensitivity: 71%, specificity: 75%, p < 0.0001) respectively. Higher baseline visfatin and fetuin-A concentrations are strongly associated with incident T2DM and are predictive of future diabetes.
研究内脏脂肪素、抵抗素、胎球蛋白 A 和趋化素与亚洲裔糖尿病前期患者发生 2 型糖尿病(T2DM)的相关性及其可能的预测作用。还研究了它们与胰岛素抵抗、β细胞功能、血糖和人体测量学的关系。这是一项针对高危人群的为期 2 年的大型前瞻性预防试验的嵌套病例对照研究。本分析选择基线 HbA1c 值为 6.0%(42mmol/mol)至 6.2%(44mmol/mol)(n=144)。在随访期间,发生 T2DM(HbA1c≥6.5%,48mmol/mol)的患者被分为病例组(n=72),血糖恢复正常(HbA1c<5.7%,39mmol/mol)的患者为对照组(n=72)。胰岛素抵抗与 T2DM 的发生相关性最强(比值比[OR]:23.22[95%CI 6.36-84.77];p<0.0001)。基线内脏脂肪素(OR:6.56[95%CI 2.21-19.5];p<0.001)和胎球蛋白 A(OR:1.01[95%CI 1.01-1.04])均独立导致糖尿病前期向 T2DM 的转化。当它们的水平升高并存时,其贡献显著更高(OR:12.63[95%CI 3.57-44.63];p<0.0001)。内脏脂肪素的曲线下面积为 0.77±SE 0.4(95%CI 0.69-0.85),胎球蛋白 A 的曲线下面积为 0.80±SE 0.04(95%CI 0.73-0.88)(内脏脂肪素中位数为 17.7ng/ml,灵敏度和特异性:75%,p<0.0001)和胎球蛋白 A(平均值 236.2μg/ml,灵敏度:71%,特异性:75%,p<0.0001)。较高的基线内脏脂肪素和胎球蛋白 A 浓度与 T2DM 的发生密切相关,并且可以预测未来的糖尿病。